1. Amirdzhanova VN, Karateev AE, Pogozheva EYu. Obzor rekomendatsii Amerikanskoi kollegii revmatologov i Amerikanskoi assotsiatsii khirurgov po perioperatsionnomu vedeniyu i antirevmaticheskoi terapii patsientov s revmaticheskimi zabolevaniyami pered total'nym endoprotezirovaniem kolennykh i tazobedrennykh sustavov -2017. Nauchno-prakticheskaya revmatologiya. 2018; 56 (5): 549-555. DOI: 10.14412/1995-4484-2018-549-555.
2. Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EU-LAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020 Jun; 79 (6): 685 doi:699. DOI: 10.1136/annrheumdis-2019-216655. PMID: 31969328.
3. Nasonov EL. Farmakoterapiya revmatoidnogo artrita: rossiiskie i mezhdunarodnye rekomendatsii. Nauchno-prakticheskaya revmatologiya. 2016; 54 (5): 557-571. DOI: 10.14412/1995-44842016-557-571.
4. Petrov VI, Cherevkova EV, Solodenkova KS, Babaeva AR. Innovatsionnye aspekty farmakoterapii revmatoidnogo artrita. Vestnik VolGMU, 2012; 1 (41): 3-9.
5. Karateev DE. Ostrye voprosy strategii lecheniya revmatoidnogo artrita. Sovremennaya revmatologiya. 2015; (1): 84-92. DOI: 10.14412/19967012-2015-1-84-92.